Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in St Denis – page 265

3 437 clinical trials in St Denis, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
St Denis at a glance
3 437
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

3 437 trials in St Denis

Open in trial search

Breast cancer+2

Not recruiting

Study on Giredestrant and Fulvestrant with CDK4/6 Inhibitor for Patients with ER+ HER2-Negative Advanced Breast Cancer Resistant to Endocrine Therapy

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:F. Hoffmann-La Roche AG

Neoplasm

Not recruiting

Study of BMS-986288 and Nivolumab for Patients with Advanced Solid Tumors

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:BMS-986288
  • Sponsor:Bristol Myers Squibb International Corporation

Study on Lorlatinib for Patients with ALK-Positive or ROS1-Positive Non-Small Cell Lung Cancer Continuing from Previous Studies

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Lorlatinib
  • Sponsor:Pfizer Inc.

Deafness bilateral

Not recruiting

Study on SENS-501 for Children with Severe Hearing Loss Due to Otoferlin Gene Mutations

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Abiraterone Acetate
  • Sponsor:Sensorion

Myelofibrosis

Not recruiting

Study of BMS-986158 Alone and with Ruxolitinib or Fedratinib for Patients with Intermediate or High Risk Myelofibrosis

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ezobresib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Hypophosphatasia

Not recruiting

Study on Immunosuppressive Therapies with Asfotase Alfa for Patients with Hypophosphatasia Experiencing Reduced Treatment Effectiveness

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Asfotase Alfa
  • Sponsor:Alexion Pharmaceuticals Inc.

Neoplasm malignant+1

Not recruiting

Study on How Larotrectinib Works in Adults with Solid Tumors with NTRK Gene Fusion

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Larotrectinib Sulfate
  • Sponsor:Bayer AG

Renal cell carcinoma

Not recruiting

Study of Pembrolizumab, Favezelimab, and Lenvatinib for Patients with Renal Cell Carcinoma

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Belzutifan
  • Sponsor:Merck Sharp & Dohme LLC

HIV infection

Not recruiting

Study Comparing Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV Treatment in Adults New to Antiretroviral Therapy

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bictegravir
  • Sponsor:Viiv Healthcare UK Limited

Study of BMS-986315 and Nivolumab with Chemotherapy for First-line Treatment in Stage IV or Recurrent Non-Small Cell Lung Cancer Patients

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:BMS-986315
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

K-ras gene mutation

Not recruiting

Study of BMS-986466 with Adagrasib and Cetuximab for Patients with KRAS G12C-mutant Advanced Solid Tumors

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Adagrasib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Study on the Safety and Effectiveness of Pembrolizumab, Lenvatinib, and Quavonlimab for Patients with Advanced Melanoma with Brain Metastases

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Lenvatinib
  • Sponsor:Merck Sharp & Dohme LLC

Other cities in France

The busiest research cities in the country

All 376 cities in France

Clinical research in St Denis

What the registry says about research in the country

01 Infectious and Respiratory Diseases

Clinical studies focusing on Chikungunya vaccination effectiveness in vulnerable populations, alongside research into ventilator-associated pneumonia treatment strategies in intensive care settings.

  • Viral infections and prevention
  • Respiratory complications
  • Antimicrobial stewardship

Research includes evaluation of treatments for Herpes Simplex Virus Encephalitis and innovative approaches to respiratory conditions.

02 Oncology Studies

Innovative research into treatment protocols for colorectal cancer and ampullary adenocarcinoma, exploring new therapeutic combinations and surgical approaches.

  • Advanced colorectal treatments
  • Neoadjuvant chemotherapy
  • Surgical outcomes

Studies focus on improving survival rates and treatment efficacy for various cancer types.

03 Autoimmune and Inflammatory Conditions

Research examining treatments for Kawasaki disease, vitiligo, and sarcoidosis, testing innovative therapeutic approaches and combination treatments.

  • Immunological responses
  • Novel treatment combinations
  • Disease management strategies

Investigations into the effectiveness of various immunomodulatory therapies and treatment protocols.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.